Show Me the "Mino:" <i>In Vitro</i> Efficacy of Minocycline on Clinical Gram-Negative Bacterial Isolates.
Our study reports the largest collection of minocycline susceptibility findings in GNB. Minocycline showed <i>in vitro</i> activity against many difficult-to-treat GNB isolates, including ceftriaxone- and multidrug-resistant <i>E. coli</i> and some <i>K. pneumoniae</i> isolates, common Amp-C-producing species, and non-fermenting GNB, including <i>Stenotrophomonas</i>, <i>Acinetobacter</i>, and <i>Achromobacter</i>.
Authors
- Nicholas Streck (ORCID: https://orcid.org/0000-0002-6704-3406)
- Christina G. Rivera (ORCID: https://orcid.org/0000-0002-8308-3264)
- Portia Mira (ORCID: https://orcid.org/0000-0003-4093-2809)
- Nischal Ranganath (ORCID: https://orcid.org/0000-0001-9538-6214)
- Douglas W. Challener (ORCID: https://orcid.org/0000-0002-6964-9639)
- Patrick Crowley (ORCID: https://orcid.org/0000-0002-3423-1179)
- O. Abu Saleh
Institutions
- Mayo Clinic (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- PubMed
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1177/10766294261424485
- Primary Topic
- Infections and bacterial resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.00